FDA Approval Activities for this Drug…

Canasa (mesalamine) Suppositories, Axcan Scandipharm NDA 21-252/S2 10/14/03 10/17/03 Canasa (mesalamine) Suppositories, Axcan Scandipharm NDA 21-252 Pentasa (Mesalamine) Capsules Roberts NDA 20-049/S006 MESALAMINE Capsule, Extended Release; 250MG PENTASA SHIRE 019618 MESALAMINE Enema; Rectal 4GM/60ML ROWASA SOLVAY 021252 MESALAMINE Suppository; Rectal 500MG CANASA AXCAN SCANDIPHARM 019651 MESALAMINE Tablet, Delayed Release; 400MG ASACOL PROCTER AND GAMBLE Pentasa (meslamine) Controlled Release Capsules, Shire Pharmaceutical, Control Supplement | Mesalamine Rectal Suspension, Clay-Park Labs, Approval | CANASA (mesalamine) Suppository, Axcan Scandipharm, Labeling Revision | Canasa (Mesalamine, USP) Rectal Suppositories, Axcan Scandipharm, New Dosage Regimen

For the latest approval information, please locate this drug using this index.